Missing/wrong data?
Log in to edit
Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6
scientific article
Author/s
author: Henry Seth Friedman, Darell D. Bigner, Allan Friedman, David A Reardon, Roger E McLendon, R. Edward Coleman, Michael R Zalutsky, Gamal Akabani
Work details
Publication date
December 12, 2007
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.